NASDAQ:MDWD Stock Quote
15.95
-1.03 (-6.07%)
Mediwound Ltd is a biotechnology company focused on developing and commercializing innovative therapies for patients with severe and chronic wounds
The company specializes in advanced wound care products and therapies, including bioactive agents that aim to promote healing and improve the quality of life for patients suffering from wounds that are difficult to treat. MediWound's commitment to research and development drives its efforts to provide effective solutions in the wound care sector, addressing both acute and chronic wound challenges in healthcare settings.

Via Benzinga · February 28, 2025

Via Benzinga · November 27, 2024

Via Benzinga · September 21, 2023

MDWD stock results show that MediWound missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Via Benzinga · July 5, 2024

Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchase orders for a total of approximately one million SecureGard syringes for 2024 delivery.
Via Benzinga · July 5, 2024

MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 29, 2024

MDWD stock results show that MediWound beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024

Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
Via Benzinga · December 28, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via Benzinga · March 21, 2024

Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is likely to report quarterly earnings at $0.11 per share on revenue of $149.42 million.
Via Benzinga · November 21, 2023

These Q4 micro-cap stocks are the ones to buy in on for long-term growth and returns to any investor's portfolio.
Via InvestorPlace · October 3, 2023

These are the micro-cap stocks to buy and they represent companies with decent fundamentals and visibility for robust growth.
Via InvestorPlace · July 11, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter.
Via Benzinga · May 30, 2023